{"address1": "44370 Old Warm Springs Boulevard", "city": "Fremont", "state": "CA", "zip": "94538", "country": "United States", "phone": "510 668 0881", "website": "https://www.abvcpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Mr. Eugene  Jiang", "age": 38, "title": "Chairman & Chief Business Officer", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Uttam Yashwant Patil Ph.D.", "age": 38, "title": "CEO & Interim CFO", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tsung-Shann  Jiang EMBA, Ph.D.", "age": 70, "title": "Chief Scientific Officer, Chief Strategy Officer & Director", "yearBorn": 1954, "fiscalYear": 2023, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.06, "open": 1.14, "dayLow": 1.11, "dayHigh": 1.4, "regularMarketPreviousClose": 1.06, "regularMarketOpen": 1.14, "regularMarketDayLow": 1.11, "regularMarketDayHigh": 1.4, "payoutRatio": 0.0, "beta": 0.67, "forwardPE": -3.0000002, "volume": 2014380, "regularMarketVolume": 2014380, "averageVolume": 558083, "averageVolume10days": 358760, "averageDailyVolume10Day": 358760, "bid": 0.9936, "ask": 1.47, "bidSize": 1, "askSize": 1, "marketCap": 31274102, "fiftyTwoWeekLow": 0.4, "fiftyTwoWeekHigh": 1.73, "priceToSalesTrailing12Months": 61.34727, "fiftyDayAverage": 0.6284, "twoHundredDayAverage": 0.640165, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 18320648, "profitMargins": 0.0, "floatShares": 9396032, "sharesOutstanding": 23692500, "sharesShort": 321400, "sharesShortPriorMonth": 257940, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0136, "heldPercentInsiders": 0.2195, "heldPercentInstitutions": 0.03887, "shortRatio": 0.24, "shortPercentOfFloat": 0.0154, "impliedSharesOutstanding": 23692500, "bookValue": 0.698, "priceToBook": 1.8911176, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -8243116, "trailingEps": -0.81, "forwardEps": -0.44, "lastSplitFactor": "1:10", "lastSplitDate": 1690243200, "enterpriseToRevenue": 35.938, "enterpriseToEbitda": -2.928, "52WeekChange": 0.023255825, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.32, "recommendationKey": "none", "totalCash": 208153, "totalCashPerShare": 0.017, "ebitda": -6256791, "totalDebt": 2745256, "quickRatio": 0.049, "currentRatio": 0.34, "totalRevenue": 509788, "debtToEquity": 34.405, "revenuePerShare": 0.051, "returnOnAssets": -0.25302, "returnOnEquity": -1.02315, "grossProfits": 369819, "freeCashflow": -2073649, "operatingCashflow": -1794994, "revenueGrowth": 23.507, "grossMargins": 0.72543997, "ebitdaMargins": 0.0, "operatingMargins": 0.17163, "financialCurrency": "USD", "symbol": "ABVC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 24.528315, "regularMarketPrice": 1.32, "marketState": "PRE", "shortName": "ABVC Biopharma, Inc.", "longName": "ABVC BioPharma, Inc.", "fiftyDayAverageChange": 0.6916, "fiftyDayAverageChangePercent": 1.1005728, "twoHundredDayAverageChange": 0.6798351, "twoHundredDayAverageChangePercent": 1.0619686, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-03", "prevName": "American BriVision (Holding) Corporation", "nameChangeDate": "2025-04-01", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1100097000000, "preMarketChange": -0.0200001, "preMarketChangePercent": -1.515159, "preMarketPrice": 1.3, "regularMarketChange": 0.2600001, "regularMarketDayRange": "1.11 - 1.4", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 558083, "fiftyTwoWeekLowChange": 0.9200001, "fiftyTwoWeekLowChangePercent": 2.3000002, "fiftyTwoWeekRange": "0.4 - 1.73", "fiftyTwoWeekHighChange": -0.40999997, "fiftyTwoWeekHighChangePercent": -0.23699419, "fiftyTwoWeekChangePercent": 2.3255825, "dividendDate": 1557273600, "earningsTimestampStart": 1743624000, "earningsTimestampEnd": 1743883200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.81, "epsForward": -0.44, "corporateActions": [], "preMarketTime": 1743582048, "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_325748154", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "ABVC BioPharma", "trailingPegRatio": null}